HomeInsightsPE

Procter & Gamble Health Ltd PE Ratio

Procter & Gamble Health Ltd PE Ratio

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Dec 6, 2024)

stocks purchased

0.9 K

Stocks Traded

(Dec 6, 2024)

Last Updated on: Dec 08, 2024

Image

Procter & Gamble Health Ltd

NSE: PGHL

PE

40.3

Last updated on: Dec 08, 2024

Key Highlights

  • The P/E Ratio of Procter & Gamble Health Ltd is 40.3 as of 08 Dec 11:38 AM .
  • The p/e ratio of Procter & Gamble Health Ltd changed from 39.9 to 41.7 over 5 quarters. This represents a CAGR of 3.59% .
  • The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 5501 as of 06 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Procter & Gamble Health Ltd

No data available

Company Fundamentals for Procter & Gamble Health Ltd

No data available

Image

Procter & Gamble Health Ltd

NSE: PGHL

Share Price

₹ 5501.7

-100.90 (-1.80%)

stock direction

Last updated on: Dec 06, 2024

Market Price of Procter & Gamble Health Ltd

1M

1Y

3Y

5Y

Monitoring Procter & Gamble Health Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Dec 20245501.7
05 Dec 20245602.6
04 Dec 20245343.5
03 Dec 20245284.3
02 Dec 20245173.15
29 Nov 20245189.95
28 Nov 20245172
27 Nov 20245201.65
26 Nov 20245303.7
25 Nov 20245135.45

SWOT Analysis Of Procter & Gamble Health Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Procter & Gamble Health Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Procter & Gamble Health Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Procter & Gamble Health Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Revenue of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical EBITDA of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Net Profit of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Dividend Payout of Procter & Gamble Health Ltd

No data available

* All values are in %

About Procter & Gamble Health Ltd

  • Procter & Gamble Health Limited (formerly Merck Limited), is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.
  • The company is the supplier of Pharmaceutical Chemicals, Formulated Chemical Products, Chemicals, Industrial Chemicals, Chemicals, Pharmaceutical Industry, and Chemical Products. The company offers prescription drugs, biotechnology products, and consumer health products, including over-the-counter products.
  • They also offer products for the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases, and other conditions with unmet medical needs. The company operates in two business divisions, namely Pharmaceuticals and Chemicals.
  • The Pharmaceuticals business comprises of Ethicals used in the treatment of Cardiovascular and Metabolic diseases & Vitamin-based formulations and Consumer Health Care Products.

Procter & Gamble Health Ltd News Hub

News

P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr

Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, ...

Read more

2024-08-22 00:00:00

News

Board of Procter & Gamble Health recommends final dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meetin...

Read more

2024-08-21 00:00:00

News

Procter & Gamble Health to pay final dividend

Procter & Gamble Health announced that final dividend of Rs 60 per share for FY 2024 will ...

Read more

2024-08-21 00:00:00

News

Broader market outperforms; European mkt opens higher

The headline equity indices traded with decent gains in afternoon trade. The Nifty hovered...

Read more

2024-08-22 00:00:00

News

Procter & Gamble Health standalone net profit declines 43.73% in the June 2024 quarter

Net profit of Procter & Gamble Health declined 43.73% to Rs 16.78 crore in the quarter end...

Read more

2024-08-22 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Procter & Gamble Health Ltd

What is the current PE Ratio of Procter & Gamble Health Ltd?

The Current PE Ratio of Procter & Gamble Health Ltd is 40.3 as on 8 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 8 Dec 2024.

What was the PE Ratio of Procter & Gamble Health Ltd last year?

The PE Ratio of Procter & Gamble Health Ltd was 37.97 last year, now the PE ratio is 40.3, showing a year-on-year growth of 6.1%.

What does the PE Ratio of Procter & Gamble Health Ltd indicate about its stock?

The PE Ratio of Procter & Gamble Health Ltd is 40.3. This ratio indicates that investors are willing to pay 40.3 times the earnings per share for each share of Procter & Gamble Health Ltd.

What is the PE Ratio Growth of Procter & Gamble Health Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Procter & Gamble Health Ltd grew by 6.1% whereas, the EPS ratio grew by 422.1.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions